- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04881708
Post-Surgical Based Efforts to Reduce Preventable Readmissions and Optimize Length of Stay (RPM)
July 7, 2022 updated by: Janani S. Reisenauer, Mayo Clinic
The investigators believe that hospital readmissions for intermediate- to high-complexity surgeries can be reduced by remote patient monitoring follow-up post-discharge, which involves daily touchpoints with a clinical nurse, vital sign evaluation and a symptom directed communication escalation process.
Study Overview
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults (over 18 years of age)
- Undergoing one of the following inpatient elective surgery procedures: abdominal wall reconstruction, bariatrics, hepatectomy, pancreatectomy, aortic surgery, lower extremity bypass, esophagectomy and colectomy at Mayo Clinic Rochester.
- Must be willing to actively work with RPM nurses with vital sign capturing.
Exclusion Criteria:
- Have uncontrolled mental illness and/or drug or alcohol abuse
- Reside in a long-term care facility
- Are being actively followed by dialysis or transplant services
- Pregnant
- Are being actively treated for cancer, receiving chemo or radiation therapy during the remote monitoring
- Are identified as end-of-life by provider
- Have dementia, cognitive impairment, or physical condition that limits ability to use home remote monitoring equipment independently or interact with remote patient monitoring staff (unless a caregiver commits to assisting daily).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Current Care Group
The current care group will receive the standard of care currently in place within the subspecialty practices in the Department of Surgery, Mayo Clinic Rochester.
This includes postoperative inpatient care directed by the surgical team, including timing of discharge and follow-up.
|
|
Active Comparator: Remote Care Group
Patients randomized to the remote monitoring arm will engage in a Connected Care Remote Patient Monitoring (RPM) Complex Care program.
RPM Complex Care programs utilize established and standardized equipment, logistics/reverse logistic, engagement methods, and nursing clinical practice.
Use of RPM Complex Care programs in this manner, is considered standard practice.
Patients will be monitored for 30 days by the Connected Care nursing team as is standard for surgical RPM Complex Care programs.
|
Subjects assigned to the Remote Care group will receive education from a clinical nurse from Mayo Clinic's Department of Connected Care on use of the equipment as part of Remote Monitoring.
The equipment will be shipped along with instructions and Welcome Letter describing the Mayo Clinic Remote Patient Monitoring program.
The Remote Patient Monitoring kit includes a digital tablet, a blood pressure cuff, a thermometer, a pulse oximeter, and a weight scale.
Subjects will be contacted by phone at the end of the study to be instructed how to return the kit by mail.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of Stay
Time Frame: Until hospital discharge, typically 3 to 7 days
|
Track the length of hospital stay in each group and compare.
|
Until hospital discharge, typically 3 to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
30-day readmission rates
Time Frame: 30 day
|
Evaluate the number of patients that are readmitted to the hospital in each group and compare.
|
30 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 19, 2021
Primary Completion (Actual)
January 17, 2022
Study Completion (Actual)
January 18, 2022
Study Registration Dates
First Submitted
May 6, 2021
First Submitted That Met QC Criteria
May 10, 2021
First Posted (Actual)
May 11, 2021
Study Record Updates
Last Update Posted (Actual)
July 8, 2022
Last Update Submitted That Met QC Criteria
July 7, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 21-000817
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
Clinical Trials on Remote Monitoring
-
University of PennsylvaniaCompletedHypertensionUnited States
-
University of PennsylvaniaCompleted
-
Abbott Medical DevicesWithdrawnHeart Failure | Cardiovascular Disease | Arrhythmias, Cardiac | Heart DiseaseUnited States
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Abbott Medical DevicesCompleted
-
Biotronik FranceBiotronik SE & Co. KGCompletedBradycardia | Pacemaker, ArtificialFrance
-
Northwestern UniversityOmron Healthcare Co., Ltd.Completed
-
Federico II UniversityRecruitingHeart Failure | Sudden Cardiac Death | Cardiac ArrhythmiasItaly
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative
-
Institut BergoniéNot yet recruiting